In plain words
Whether can harm people or the environment, and how to work with them safely. There is no single answer for “graphene”: the size, thickness, surface chemistry and dose of the decide what they do in the body, and a material bound inside a plastic is a very different matter from a fine powder in the air. Some chemicals used to make 2D materials – hydrofluoric acid, hydrogen selenide – are far more dangerous than the materials themselves.
Going deeper
Form, not name
“Graphene” covers everything from a pristine to an oxidised powder, and these behave very differently in the body. What matters is the size, thickness, stiffness and surface chemistry of the flakes, whether they clump or stay dispersed, how much reaches the body and by which route. Small, thin, oxygen-rich flakes tend to be taken up and cleared by immune cells, while large, stiff platelets can be too big to engulf completely – a problem that partly resembles the one posed by long asbestos fibres, and a reason platelet size is watched closely.
In a controlled trial published in 2024, healthy volunteers inhaled highly purified, very small graphene oxide flakes for two hours without measurable effects on lung function, blood pressure or markers of inflammation – reassuring, though it says nothing about long-term or high-dose exposure.
What the materials contain
Some 2D materials are hazardous because of their elements. Lead perovskites contain lead, and several chalcogenides and pnictides contain selenium, tellurium, arsenic or antimony, whose release during processing or from discarded devices needs control. Black phosphorus and degrade in air and water into other compounds whose effects differ from those of the original flakes. A lead-free or low-toxicity alternative is therefore often part of a material’s appeal, as for bismuth oxyhalide photocatalysts.
Making them safely
The greater risk often lies in production. Growing selenides and sulfides by uses hydrogen selenide and hydrogen sulfide, highly toxic gases that need gas cabinets and detectors; making MXenes uses hydrofluoric acid or fluoride salts in acid, which burn and poison through the skin; some organometallic precursors ignite in air. Dry powders are handled like other fine powders, in enclosures with extraction and suitable masks, while flakes bound inside a or a device are generally regarded as a low risk to users. Under European law, nanoforms of a substance are registered and described separately under .
For specialists
The hazard assessment of 2D materials and their production. Biological effects of graphene-family and other nanosheets depend on lateral size, thickness, stiffness, surface chemistry, dispersibility and dose rather than on the name: large, stiff platelets can frustrate macrophages in a partly asbestos-like way, while small, oxidised, well-dispersed flakes are cleared more readily, and a first controlled human inhalation study of small, thin graphene oxide in 2024 found no acute cardiorespiratory effects. Some compounds carry intrinsic toxicity (lead in halide perovskites; selenium, tellurium, arsenic, antimony), and processes use hazardous precursors – H2S, H2Se, HF, organometallics. Nanoforms are registered separately under REACH; workplace exposure is managed as for fine powders, and exposure from flakes bound in composites is generally considered low.
Where this comes from
- Graphene-based nanoplatelets: a new risk to the respiratory system as a consequence of their unusual aerodynamic properties
- Safety assessment of graphene-based materials: focus on human health and the environment
- First-in-human controlled inhalation of thin graphene oxide nanosheets to study acute cardiorespiratory responses